CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 8-K Event Material agreement · Agreement ended
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale See remarks sold 12,103 shares at an average $3.02 ($36,541)
- 4 Planned sale Chief Financial Officer sold 19,191 shares at an average $3.07 ($58,849)
- 4 Open-market sale President, R&D sold 31,562 shares at an average $3.02 ($95,381)
- 4 Open-market sale Chief Legal Officer sold 14,587 shares at an average $3.02 ($44,040)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale President and CEO sold 61,422 shares at $2.97 ($182,423)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale President, R&D sold 986 shares at $2.84 ($2,800)
Page 7 of 28 · 556 filings